Regener8 enables the translation of university and industry research in regenerative medicine into commercial products and clinical benefits.
By bringing together world-leading scientists in the N8 universities and beyond, translational clinicians and international industry, we enhance early stage innovation and develop translational capability to nurture technologies and understanding and progress regenerative therapies through to the clinic and the market.
4 May 2016
22 Apr 2016
11 Apr 2016